Child Health Department, Medical School, University of Ioannina, P.O. Box 1187, 45110 Ioannina, Greece.
Eur J Pediatr. 2013 Apr;172(4):557-61. doi: 10.1007/s00431-012-1798-1. Epub 2012 Aug 9.
Kearns-Sayre syndrome (KSS) is a rare mitochondrial DNA deletion syndrome defined as the presence of ophthalmoplegia, pigmentary retinopathy, onset less than age 20 years, and one of the following: cardiac conduction defects, cerebellar syndrome, or cerebrospinal fluid protein above 100 mg/dl. KSS may affect many organ systems causing endocrinopathies, encephalomyopathy, sensorineural hearing loss, and renal tubulopathy. Clinical presentation at diagnosis is quite heterogeneous and, usually, few organs are affected with progression to generalized disease early in adulthood. We present the case of a boy with KSS presenting at the age of 5 years with myopathy, Addison's disease, primary hypoparathyroidism, and Fanconi syndrome. The proper replacement treatment along with the administration of mitochondrial metabolism-improving agents had a brief ameliorating effect, but gradual severe multisystemic deterioration was inevitable over the next 5 years.
This report highlights the fact that in case of simultaneous presentation of polyendocrinopathies and renal disease early in childhood, KSS should be considered.
Kearns-Sayre 综合征(KSS)是一种罕见的线粒体 DNA 缺失综合征,其定义为存在眼肌麻痹、色素性视网膜炎、发病年龄小于 20 岁,以及以下一种或多种情况:心脏传导缺陷、小脑综合征或脑脊液蛋白高于 100mg/dl。KSS 可能影响许多器官系统,导致内分泌疾病、脑肌病、感觉神经性听力损失和肾小管病。诊断时的临床表现非常多样化,通常只有少数器官受累,随着疾病的进展,成年早期会出现全身性疾病。我们报告了一例 KSS 患儿,在 5 岁时出现肌病、艾迪生病、原发性甲状旁腺功能减退症和范可尼综合征。适当的替代治疗以及线粒体代谢改善剂的使用有短暂的改善作用,但在接下来的 5 年内,不可避免地会出现逐渐严重的多系统恶化。
本报告强调了一个事实,即在儿童早期同时出现多内分泌疾病和肾脏疾病时,应考虑 KSS。